Skip to content

The Effectiveness of Psychological Treatment in adults with cannabis use disorder

The Effectiveness of Matrix Treatment on Craving and Psychological Capital in cannabis users

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240723062524N1
Enrollment
60
Registered
2024-07-27
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Cannabis Use Disorder (CUD). Condition 2: Cannabis Withdrawal Disorder (CWD). Cannabis abuse Cannabis dependence

Interventions

Intervention 1: The first intervention group consists of mild cannabis users who receive matrix intervention in 8 to 12 sessions based on family counseling, cognitive-behavioral therapy (CBT), motivat

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: According to the fifth edition of the Diagnostic and Statistical Mental Health Analysis, Text Revision Criteria (DSM-5-TR), participants must have at least twelve months of experience with marijuana use. They must also avoid stimulant drugs other than cigarettes and marijuana. The participants must be between 18 and 50 years of age and have signed an ethical form indicating their consent.

Exclusion criteria

Exclusion criteria: Participants who require more advanced care than what an outpatient group can provide, such as those experiencing active mania or psychosis. Any psychiatric or physical condition may find it challenging to communicate effectively. The participant is concurrently receiving another medical or psychological intervention that is based on cognitive behavior therapy. Participants who are unavailable during study sessions and have missed more than four sessions.

Design outcomes

Primary

MeasureTime frame
Marijuana Craving Score. Timepoint: Before and after the intervention. Method of measurement: Marijuana Craving Questionnaire (MCQ).;Diagnosis of cannabis use and severity. Timepoint: At the onset of both the study and the intervention. Method of measurement: The Structured Clinical Interview for Clinical Trials version (SCID-5-CT).;Psychological Capital Score. Timepoint: Before and after the intervention. Method of measurement: Psychological Capital Questionnaire (PCQ).;Diagnosis of cannabis use and severity. Timepoint: At the onset of the study and one month after the completion of the intervention,. Method of measurement: The Cannabis Use Disorders Identification Test (CUDIT-R-Pr) has been revised in Persian.;Negative urine test for cannabis. Timepoint: Before intervention and 3, 6, 9, 12 and 16 weeks after intervention. Method of measurement: Cannabis urine test.

Secondary

MeasureTime frame
Patient Health Score. Timepoint: Before and after the intervention. Method of measurement: Patient Health Questionnaire (PHQ-9).;General Anxiety Disorder Score. Timepoint: Before and after the intervention. Method of measurement: General Anxiety Disorder Questionnaire (GAD-7).;The Marijuana Withdrawal Checklist to assess the incidence and severity of perceived withdrawal symptoms. Timepoint: Before and after the intervention. Method of measurement: The Marijuana Withdrawal Checklist (MWC).;Self-Efficacy Score to abstinence from marijuana. Timepoint: Before and after the intervention. Method of measurement: The Self-Efficacy Questionnaire (SEQ) for abstinence from marijuana.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Mollazadeh

Islamic Azad University

alimollazade@yahoo.com+98 86 3722 2500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026